SangYun Kim
Seoul National University Bundang Hospital
237 Papers
581 Citations
SangYun Kim is an academic researcher from Seoul National University Bundang Hospital. The author has contributed to research in topics: Dementia & Medicine. The author has an hindex of 30, co-authored 236 publications. Previous affiliations of SangYun Kim include New Generation University College.
Chat about Author
Papers
A Consensus in Korea Regarding a Protocol to Reduce Preanalytical Sources of Variability in the Measurement of the Cerebrospinal Fluid Biomarkers of Alzheimer's Disease
Sun Ah Park,Ju-Hee Kang,Ju-Hee Kang,Eun Suk Kang,Chang-Seok Ki,Jee Hoon Roh,Young Chul Youn,Seong Yoon Kim,SangYun Kim +8 more
TL;DR: Following a review of the procedures used in Korean and international biomarker laboratories, a consensus was reached among a cooperative Korean multicenter research group regarding a standardized protocol for the analysis of AD biomarkers in CSF, thus minimizing the confounding influence of various factors on current investigations and on future studies using novel biomarkers of AD and other neurodegenerative disorders.
A Comparative Evaluation of the KDSQ-C, AD8, and SMCQ as a Cognitive Screening Test to Be Used in National Medical Check-ups in Korea.
Ahro Kim,SangYun Kim,Kyung Won Park,Kee Hyung Park,Young Chul Youn,Dong Woo Lee,Jun-Young Lee,Jun Hong Lee,Jee Hyang Jeong,Seong Hye Choi,Hyun Jeong Han,Semi Kim,Seunghee Na,Mi Sun Park,Hyeon Woo Yim,Dong Won Yang +15 more
TL;DR: It is recommended that the Korean Dementia Screening Questionnaire-Cognition continues to be used in national medical check-ups as its discriminability for dementia is not different from that of the AD8 or SMCQ.
Driving Cessation and Cognitive Dysfunction in Patients with Mild Cognitive Impairment.
TL;DR: In patients with MCI, poor performance in the digit span backward test, which represents impaired working memory capacity, was associated with a higher probability of driving cessation and the predictive value of cognitive performances for driving cessation.
18
Novel PSEN1 p.Gly417Ala mutation in a Korean patient with early-onset Alzheimer's disease with parkinsonism
TL;DR: A 37-year-old male Korean patient carrying a PSEN1 p.Gly417Ala mutation with exceptionally early and severe presentations is reported, including a wide range of atypical symptoms of rapid cognitive decline with a stooped posture, rigidity, and bradykinesia.
17
Identification of a novel mutation in APP gene in a Thai subject with early-onset Alzheimer's disease
TL;DR: A 3D protein structure model revealed that V604M exchange could result in significant changes in the APP protein due to the increased hydrophobicity of methionine in the helix, which could results in altering of the APP functions.